One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and ...
Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.
Bacteria in the human gut can directly deliver proteins into human cells, actively shaping immune responses. A consortium led ...
New therapy reprograms immune cells inside tumors to attack cancer, bypassing traditional cell therapy manufacturing ...
While the fabled fountain of youth may not actually exist, a new type of therapy now does.
A new standard in wheat immune reactivity testing that adds seven new wheat markers to assess immune responses to ...
A protein notorious for its role in Alzheimer’s disease may hold the key to supercharging the aging immune system, according to new research. Scientists have found that a byproduct of amyloid-beta ...
A brain protein called ANO2 has emerged as a new piece of the puzzle linking Epstein-Barr virus (EBV) infections and MS damage.
DNA is often described as the instruction manual for building the fundamental components of life. Proteins are helpers that ...
News Medical on MSN
EBV-linked killer T cells implicated in multiple sclerosis
Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Researchers have found that patients with amyotrophic lateral sclerosis have ...
Live Science on MSN
'Nose-in-a-dish' reveals why the common cold hits some people hard, while others recover easily
Using a laboratory model of the human nose, scientists have investigated why the severity of common-cold infections varies so widely between individuals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results